BOLD
Boundless Bio, Inc.Company with tickers: BOLD
CIK
1782303
CUSIP
10170A100
Shares Outstanding
22,464,111
13F Activity (30d)
34 filings
34 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $14,475,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $9,734,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-14,475,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-13,555,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-0.60 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-0.60 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |